Navigation Links
Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL(R) for Treatment of Advanced Breast Cancer
Date:7/15/2009

HORSHAM, Pa., July 15 /PRNewswire/ -- Based on the data presented today, the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended that the combination of DOXIL(R) (doxorubicin HCI liposome injection) and docetaxel did not provide a sufficient benefit-risk profile for the treatment of women with locally advanced or metastatic breast cancer.

Women with locally advanced and metastatic breast cancer who have received prior anthracycline treatment have special treatment challenges, and Centocor Ortho Biotech Products, L.P. remains committed to bringing them new therapeutic options. The company believes the DOXIL-docetaxel combination has an important role in the treatment of advanced breast cancer and will work with the FDA to address the committee's concerns.

The committee provides non-binding recommendations based on its evaluation. The final decision regarding approval of the drug will be made by the FDA.

About DOXIL(R)( )

DOXIL is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after prior platinum-based therapy. DOXIL in combination with VELCADE(R) (bortezomib) is indicated for the treatment of patients with multiple myeloma who have not previously received VELCADE and have received at least one prior therapy. DOXIL is also indicated for the treatment of AIDS-related Kaposi's sarcoma in patients after failure of prior systemic chemotherapy or intolerance to such therapy.

DOXIL is marketed in the United States by Centocor Ortho Biotech Products, L.P., and in Israel by Janssen-Cilag. Schering-Plough Corporation, under a licensing agreement, has exclusive rights to market the medication as CAELYX throughout the rest of the world, excluding Japan and Israel
'/>"/>

SOURCE Centocor Ortho Biotech Products, L.P.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer
2. Centocor R&D and University of Michigan Forge New Model for Academic/Industry Partnerships
3. FASgen, Inc. Announces Research and License Agreement With Centocor, Inc.
4. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
5. MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks
6. Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
7. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
8. Renowned, Cleveland Clinic Foundation, Orthopaedic Sports Medicine Surgeon, John Bergfeld, MD, Inducted into Sports Medicine Hall of Fame
9. American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting
10. James R. Andrews, Renowned Orthopaedic Surgeon, Installed as AOSSM President
11. Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... comprised over 24,000 Finnish subjects and was led ... a panel of 28 genetic markers improved detection ... disease (CHD) (10-year risk ≥20%) over traditional risk ... important preventive strategy for CHD, because the current ... "The results indicate that genetic markers could be ...
(Date:5/20/2013)... May 20, 2013 BenefitMall, ... employee benefit, payroll products and services and CompuPay, ... are selected as finalists for the 2013 American Business ... of the Year category, and CompuPay is a finalist ... will ultimately be a Gold, Silver or Bronze Stevie® ...
(Date:5/20/2013)... 20, 2013 With the economic recession taking ... of coupons has seen a significant rise. Jessica Hacker proclaims ... coupons one way or the other. However, some people are ... as an ineffective measure to save money. Therefore, in order ... masses about its use, the online classes offered by Jessica ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Dr. Fanny J ... Brilliant, a gentle fractional laser treatment clinically proven to fight ... Clear + Brilliant are designed to prevent and ... + Brilliant can visibly illuminate skin tone, renew and smoothen ... skin, and reduce the appearance of pores. Developed by the ...
(Date:5/20/2013)... SUNDAY, May 19 (HealthDay News) -- Sleep apnea, the ... and subconsciously waking them up, becomes more common as ... possibility that it may somehow cause -- or be ... just yet if you have sleep apnea. The research ... no connection between the two conditions. Still, scientists found ...
Breaking Medicine News(10 mins):Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 3Health News:Online Couponing Classes Offered by Jessica Hacker to Save Hundreds of Dollars 2Health News:Delaware Dermatologist Now Offers Clear + Brilliant Gentle Laser Skin Rejuvenation Treatments 2Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 2Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 3
... The following was,released today by the Democratic National ... cash in Saint Louis today,56,900 uninsured children in Missouri ... will finally say whether he supports,President Bush,s threat to ... week, President Bush is expected to veto a Democratic ...
... that typically fight bacteria, study finds , MONDAY, Oct. ... urban air pollution, shuts down early immune responses in ... vulnerable to bacteria and other foreign invaders, research shows. ... with increased cardiovascular and pulmonary hospitalizations and deaths, but ...
... Team that Provided Critical Services ... to Over 1,000 in 5 ... half of the husband and wife team that makes up La ... usually focus their attention on the dental needs of their North,County ...
... 1 Consumers are more concerned than ever,about the products ... is now more than just an every day routine, it ... Pure & Natural introduces a,new line of personal care products, ... new product line delivers more than just personal,care benefits; it ...
... Mich., Oct. 1 In an effort to,communicate ... it relates to,adult and embryonic stem cell research, ... bishops have launched a monumental,internal statewide education program ... parishes., The Church,s support for adult stem ...
... Cheryl Servais, MPH, RHIA, VP of Compliance and ... for a legal health record, WAYNE, Pa., ... peak performance within Health Information Management (HIM),departments, today ... Officer, Cheryl Servais, MPH, RHIA, authored The Legal ...
Cached Medicine News:Health News:Missouri Children to Mitt Romney: Show Me Your Health Care Priorities 2Health News:San Diego Dentist Haunted by Smiles in Dominican Republic 2Health News:Pure & Natural: Introducing an Effective, Healthy Approach to Personal Care and Beyond 2Health News:Pure & Natural: Introducing an Effective, Healthy Approach to Personal Care and Beyond 3Health News:Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program 2Health News:Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program 3Health News:Precyse Executive Authors New Book, The Legal Health Record 2
(Date:5/17/2013)... 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... for industry, healthcare and to first responders on the ... results for the fiscal 2013 fourth quarter and year ... at stock market close and will conduct a conference ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
(Date:5/17/2013)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today announced ... Global Healthcare Conference in New York . ... at 11 a.m. Eastern Time. To listen to the live ... Investor Relations section of the Company,s Web site at ... after the event. About Orexigen® Therapeutics Orexigen ...
(Date:5/17/2013)... May 17, 2013   Shareholder rights attorneys  at ... Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a complaint ... Massachusetts .  The complaint alleges that ... Exchange Act of 1934 (the "Exchange Act") between January ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
... ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ACCP) announced ... performed by Access collaborators at two,prominent institutes ... the joint,symposium of the American Association for ... European Organization for Research and Treatment,of Cancer ...
... Cells has Potential to Yield High ... and Therapeutic Products, ST. LOUIS and RICHMOND, Calif., Oct. ... Inc.,(Nasdaq: SGMO ) announced today the publication of data ... human stem,cells. This work represents a significant advance in the ...
Cached Medicine Technology:Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 2Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 3Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 2Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 3Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 4Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells 5
... acclaimed GT-CAPTURE digital camera photomicrographic system can ... such as Olympus, Leica, Nikon, and Zeiss, ... transferring images over the Internet easy and ... a performance-proven Nikkor lens. The system records ...
... digital camera photomicrographic system can be mounted ... Olympus, Leica, Nikon, and Zeiss, making building ... over the Internet easy and fast. Featuring ... Nikkor lens. The system records photomicrographic images ...
... Brilliant digital images with advanced ... Stepping) high density imaging technology offers ... up to 12 million output pixels ... enabling enlarged image data for documentation ...
... from Carl Zeiss developed ... microscopy expert. Not only does ... in all image formats, it ... work with the microscope and ...
Medicine Products: